Radiopharmeaceuticals

Radiopharmaceuticals are drugs that contain radioactive materials, known as radioisotopes. These drugs may be administered by multiple routes and travel to the body to treat cancer or to reduce symptoms. Radiopharmaceuticals release radiation (alpha and beta particles) that target the affected areas.
 
Everyone responds to radiopharmaceuticals differently. Talk to your doctor or pharmacist about what to expect, including any side-effects you may experience while on these medications. Some therapies used to treat prostate cancer may interact with other prescription or non-prescription medications you are taking. Tell your doctor or pharmacist if you are taking any medications.
 
Below is a list of common radiopharmaceuticals used to treat prostate cancer. Click on each drug name for further information including:
 
  • what the drug is and how it works
  • how the drug is administered
  • possible side effects of the drug
  • whether the drug is covered by your provincial drug program

Radium 223 Dichloride (Xofigo)
 




 

Donate Now!

Tell Ontario to fund the PSA test


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.
More

Researchers discover common markers of tumour hypoxia across 19 cancer types

Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumours
More

Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More


Click here for news archive